Annual Total Debt
$6.14 B
-$981.04 M-13.79%
31 December 2023
Summary:
Royalty Pharma annual total debt is currently $6.14 billion, with the most recent change of -$981.04 million (-13.79%) on 31 December 2023. During the last 3 years, it has fallen by -$960.78 million (-13.54%). RPRX annual total debt is now -13.79% below its all-time high of $7.12 billion, reached on 31 December 2022.RPRX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$7.61 B
+$5.36 M+0.07%
30 September 2024
Summary:
Royalty Pharma quarterly total debt is currently $7.61 billion, with the most recent change of +$5.36 million (+0.07%) on 30 September 2024. Over the past year, it has increased by +$1.47 billion (+23.99%). RPRX quarterly total debt is now at all-time high.RPRX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPRX Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +24.0% |
| 3 y3 years | -13.5% | +7.2% |
| 5 y5 years | -1.6% | +21.9% |
RPRX Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -13.8% | at low | at high | +24.1% |
| 5 y | 5 years | -13.8% | +5.5% | at high | +30.9% |
| alltime | all time | -13.8% | at high |
Royalty Pharma Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $7.61 B(+0.1%) |
| June 2024 | - | $7.60 B(+23.8%) |
| Mar 2024 | - | $6.14 B(+0.1%) |
| Dec 2023 | $6.14 B(-13.8%) | $6.14 B(+0.1%) |
| Sept 2023 | - | $6.13 B(-14.0%) |
| June 2023 | - | $7.13 B(+0.1%) |
| Mar 2023 | - | $7.12 B(+0.1%) |
| Dec 2022 | $7.12 B(+0.3%) | $7.12 B(+0.1%) |
| Sept 2022 | - | $7.11 B(+0.1%) |
| June 2022 | - | $7.11 B(+0.1%) |
| Mar 2022 | - | $7.10 B(+0.1%) |
| Dec 2021 | $7.10 B | $7.10 B(+0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $7.09 B(+21.7%) |
| June 2021 | - | $5.83 B(+0.1%) |
| Mar 2021 | - | $5.82 B(+0.1%) |
| Dec 2020 | $5.82 B(-6.8%) | $5.82 B(+0.1%) |
| Sept 2020 | - | $5.81 B(-1.7%) |
| June 2020 | - | $5.91 B(-0.8%) |
| Mar 2020 | - | $5.96 B(-4.5%) |
| Dec 2019 | $6.24 B(-4.3%) | $6.24 B(>+9900.0%) |
| Sept 2019 | - | $0.00(0.0%) |
| June 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00 |
| Dec 2018 | $6.52 B(>+9900.0%) | - |
| Dec 2017 | $0.00 | - |
FAQ
- What is Royalty Pharma annual total debt?
- What is the all time high annual total debt for Royalty Pharma?
- What is Royalty Pharma quarterly total debt?
- What is the all time high quarterly total debt for Royalty Pharma?
- What is Royalty Pharma quarterly total debt year-on-year change?
What is Royalty Pharma annual total debt?
The current annual total debt of RPRX is $6.14 B
What is the all time high annual total debt for Royalty Pharma?
Royalty Pharma all-time high annual total debt is $7.12 B
What is Royalty Pharma quarterly total debt?
The current quarterly total debt of RPRX is $7.61 B
What is the all time high quarterly total debt for Royalty Pharma?
Royalty Pharma all-time high quarterly total debt is $7.61 B
What is Royalty Pharma quarterly total debt year-on-year change?
Over the past year, RPRX quarterly total debt has changed by +$1.47 B (+23.99%)